Candidiasis
📧 Sign up to get email alerts when something new happens for Candidiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-08FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for voriconazole from Zydus Lifesciences Limited, indicating an approval of the supplemental submiss…
-
FDA approval · 2023-07-17FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride, establishing an intravenous formulation of fluconazole. …
-
FDA approval · 2023-07-14FDA Approved: FLUCONAZOLE — Supplemental Application (Baxter Healthcare Company)
FDA approved Baxter Healthcare Company's supplemental application for fluconazole (ANDA076766). This action confirms authorization of a gene…
-
FDA approval · 2023-03-17FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluconazole submitted by Rising Pharma Holdings, Inc., indicating approval of a generic formulat…
-
FDA approval · 2022-12-08FDA Approved: POSACONAZOLE — Original Application (NorthStar RxLLC)
The FDA approved NorthStar RxLLC's original application for posaconazole, granting authorization for a generic posaconazole product (ANDA 21…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-11-17FDA Approved: AMPHOTERICIN B — Original Application (Eugia US LLC)
FDA approved the original ANDA for Amphotericin B from Eugia US LLC, authorizing a generic Amphotericin B product.
-
FDA approval · 2022-08-16FDA Approved: VORICONAZOLE — Supplemental Application (Xellia Pharmaceuticals USA LLC)
FDA approved a supplemental application for Voriconazole by Xellia Pharmaceuticals USA LLC.
-
FDA approval · 2022-07-28FDA Approved: POSACONAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for posaconazole delayed-release (POSACONAZOLE DELAYED-RELEASE) from Chartwell RX, LLC, updating its…
-
FDA approval · 2022-05-25FDA Approved: POSACONAZOLE — Original Application (Par Health USA, LLC)
FDA approved the original application for posaconazole (generic) by Par Health USA, LLC, marking the availability of a generic posaconazole …
-
FDA approval · 2022-02-04FDA Approved: POSACONAZOLE — Original Application (Biocon Phama Inc.)
FDA approved Biocon Phama Inc.'s original application for posaconazole, authorizing a generic formulation of the antifungal agent.
-
FDA approval · 2021-12-14FDA Approved: AMPHOTERICIN B — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' original application for Amphotericin B, confirming a generic version of the antifungal. The…
-
FDA approval · 2021-10-25FDA Approved: DIFLUCAN — Supplemental Application (Roerig)
The FDA approved a supplemental application for Diflucan (fluconazole) submitted by Roerig.
-
FDA approval · 2021-10-06FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for fluconazole from Rising Pharma Holdings, Inc., related to this generic antifungal product.
-
FDA approval · 2021-02-01FDA Approved: POSACONAZOLE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved the original application for posaconazole from Lupin Pharmaceuticals, enabling generic availability of the antifungal.
-
FDA approval · 2021-01-14FDA Approved: NYSTATIN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an Original Application for NyStatin (nystatin) by Macleods Pharmaceuticals Limited, establishing a generic antifungal product.…
-
FDA approval · 2020-09-16FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved Merck's supplemental application for NOXAFIL (posaconazole), updating the product labeling with new indications/usage detai…
-
FDA approval · 2020-06-22FDA Approved: FLUCONAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for fluconazole submitted by Chartwell RX, LLC.
-
FDA approval · 2020-02-18FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
The FDA approved a supplemental application for Ketoconazole filed by Thirty Madison Inc, resulting in updates to the Ketoconazole product l…
-
FDA approval · 2019-07-24FDA Approved: NYSTATIN — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the Original Application for Nystatin from Torrent Pharmaceuticals Limited, authorizing a generic antifungal product.
-
FDA approval · 2019-04-23FDA Approved: NYSTATIN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Nystatin ointment from Cosette Pharmaceuticals, Inc. The approval indicates regulatory clearance…
-
FDA approval · 2018-06-18FDA Approved: KETOCONAZOLE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original ANDA for Ketoconazole, a generic antifungal product, covering common dermatophytic an…
-
FDA approval · 2018-05-25FDA Approved: NYSTATIN — Original Application (Viona Pharmaceuticals Inc)
FDA approved NYSTATIN as an Original Application (ANDA 207767) for a generic nystatin product by Viona Pharmaceuticals Inc.
-
FDA approval · 2018-05-21FDA Approved: NYSTATIN — Original Application (Leading Pharma, LLC)
The FDA has approved an original ANDA for NYSTATIN from Leading Pharma, LLC.
-
FDA approval · 2017-10-06FDA Approved: NYSTATIN — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved the original application for Nystatin Ointment from Cosette Pharmaceuticals, Inc., granting a new generic topical antifungal pr…
-
FDA approval · 2017-09-26FDA Approved: NYSTATIN CREAM — Original Application (Crown Laboratories)
FDA approves Crown Laboratories' Nystatin Cream as an original generic topical antifungal (ANDA 207733) indicated for candidiasis, including…